Display Settings:

Format

Send to:

Choose Destination
    Mol Chem Neuropathol. 1990 Mar;12(2):121-9; discussion 143-5.

    Arylsulfatase A (ASA) defect and psychiatric illness. A review.

    Source

    University of California, San Francisco, Brain-Behavior Research Center, Sonoma Development Center, Eldridge 95431.

    Abstract

    The detection of homozygous (disease state) and heterozygous (carrier) forms of metachromatic leukodystrophy (MLD) and their prevalence among psychiatric individuals are reviewed. Levels of Arylsulfatase A (ASA) activity in peripheral leukocytes, mixed white cell populations, and lymphocytes are compared in normal and psychiatric patients. The prevalence of low levels of enzyme activity in psychiatric patients, and the implications of such levels with regard to the metabolic disease states and associated psychiatric illnesses are discussed. In addition, the use and reliability of leukocyte enzyme assay systems as a criteria for determining and distinguishing between the homozygous and heterozygous conditions are evaluated.

    PMID:
    1981468
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk